Gilead Sciences (GILD): analysis and statistics
Return, volatility, Sharpe ratio and risk for Gilead Sciences, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $131.28 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +24.06% |
| Total return over period | +90.30% |
| Annualized volatility | 25.96% |
| Sharpe ratio | 0.79 |
| Sortino ratio | 1.20 |
| Max drawdown | -26.59% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.26% |
| Correlation with the S&P 500 | 0.21 |
| Period range | $59.16 – $153.91 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Gilead Sciences (GILD) has posted an annualized return of +24.06% with annual volatility of 25.96%, a Sharpe ratio of 0.79. Its worst stretch (max drawdown from a peak) was -26.59%. Its correlation with the S&P 500 is 0.21, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how GILD would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with GILD →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio